The challenges of novel contrast agents for the imaging diagnosis of hepatocellular carcinoma
- PMID: 26202400
- DOI: 10.1007/s12072-013-9505-5
The challenges of novel contrast agents for the imaging diagnosis of hepatocellular carcinoma
Similar articles
-
Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.J Ultrasound Med. 2015 Mar;34(3):423-33. doi: 10.7863/ultra.34.3.423. J Ultrasound Med. 2015. PMID: 25715363
-
Ongoing challenges in the diagnosis of hepatocellular carcinoma.Expert Rev Gastroenterol Hepatol. 2016;10(4):451-63. doi: 10.1586/17474124.2016.1124758. Epub 2015 Dec 19. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26603785 Review.
-
Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.J Ultrasound Med. 2016 Jul;35(7):1383-91. doi: 10.7863/ultra.15.08042. Epub 2016 May 20. J Ultrasound Med. 2016. PMID: 27208196
-
Contrast-enhanced ultrasonography: a recent application for the diagnosis and treatment of hepatocellular carcinoma.JNMA J Nepal Med Assoc. 2008 Jul-Sep;47(171):156-66. JNMA J Nepal Med Assoc. 2008. PMID: 19079385 Review.
-
Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma.AJR Am J Roentgenol. 2009 Mar;192(3):686-92. doi: 10.2214/AJR.08.1255. AJR Am J Roentgenol. 2009. PMID: 19234264
Cited by
-
MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid.Sci Rep. 2022 Nov 3;12(1):18583. doi: 10.1038/s41598-022-23397-1. Sci Rep. 2022. PMID: 36329107 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources